Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 878706

Lipid/alginate nanoparticle-loaded in situ gelling system tailored for dexamethasone nasal delivery


Jurišić Dukovski, Bisera; Plantić, Iva; Čunčić, Ivan; Krtalić, Iva; Juretić, Marina; Pepić, Ivan; Lovrić, Jasmina; Hafner, Anita
Lipid/alginate nanoparticle-loaded in situ gelling system tailored for dexamethasone nasal delivery // International journal of pharmaceutics, 533 (2017), 2; 480-487 doi:10.1016/j.ijpharm.2017.05.065 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 878706 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Lipid/alginate nanoparticle-loaded in situ gelling system tailored for dexamethasone nasal delivery

Autori
Jurišić Dukovski, Bisera ; Plantić, Iva ; Čunčić, Ivan ; Krtalić, Iva ; Juretić, Marina ; Pepić, Ivan ; Lovrić, Jasmina ; Hafner, Anita

Izvornik
International journal of pharmaceutics (0378-5173) 533 (2017), 2; 480-487

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
nasal delivery ; in situ gelling ; alginate ; amidated pectin ; dexamethasone

Sažetak
In this study, we suggest the development of nanoparticle loaded in situ gelling system suitable for corticosteroid nasal delivery. We propose lipid/alginate nanoparticles (size 252.3 ± 2.4 nm, polydispersity index 0.241, zeta-potential −31.7 ± 1.0 mV, dexamethasone (Dex) content 255 ± 7 μg ml−1) dispersed in pectin solution (5 mg ml−1) that undergoes a sol-gel phase transition triggered by Ca2+ present in nasal mucosa. The viscoelasticity of gel obtained by mixing nanoparticle suspension in pectin continuous phase with simulated nasal fluid (1:1 V/V) is characterized by a log- linear shear thinning viscosity behaviour. Observed viscosity corresponds to the range of viscosities of nasal mucus at physiological as well as under disease conditions. Nanoparticle- loaded gel was biocompatible with the selected epithelial cell model and, in comparison to dexamethasone solution, provided reduction in Dex release (t50% 2.1 h and 0.6 h, respectively) and moderated transepithelial permeation in vitro (Papp 7.88 ± 0.15 and 9.73 ± 0.57 × 10−6 cm s−1, respectively). In conclusion, this study showed the potential of the proposed system to provide local therapeutic effect upon administration of a lower corticosteroid dose and minimize the possibility for adverse effects as it can be easily sprayed as solution and delivered beyond nasal valve, ensure prolonged contact time with nasal mucosa upon gelation, and moderate corticosteroid release and permeation.

Izvorni jezik
Engleski

Znanstvena područja
Farmacija



POVEZANOST RADA


Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
PLIVA HRVATSKA d.o.o.

Profili:

Avatar Url Jasmina Lovrić (autor)

Avatar Url Marina Juretić (autor)

Avatar Url Anita Hafner (autor)

Avatar Url IVA KRTALIĆ (autor)

Avatar Url Ivan Pepić (autor)

Avatar Url Bisera Jurišić (autor)

Poveznice na cjeloviti tekst rada:

doi www.sciencedirect.com

Citiraj ovu publikaciju:

Jurišić Dukovski, Bisera; Plantić, Iva; Čunčić, Ivan; Krtalić, Iva; Juretić, Marina; Pepić, Ivan; Lovrić, Jasmina; Hafner, Anita
Lipid/alginate nanoparticle-loaded in situ gelling system tailored for dexamethasone nasal delivery // International journal of pharmaceutics, 533 (2017), 2; 480-487 doi:10.1016/j.ijpharm.2017.05.065 (međunarodna recenzija, članak, znanstveni)
Jurišić Dukovski, B., Plantić, I., Čunčić, I., Krtalić, I., Juretić, M., Pepić, I., Lovrić, J. & Hafner, A. (2017) Lipid/alginate nanoparticle-loaded in situ gelling system tailored for dexamethasone nasal delivery. International journal of pharmaceutics, 533 (2), 480-487 doi:10.1016/j.ijpharm.2017.05.065.
@article{article, author = {Juri\v{s}i\'{c} Dukovski, Bisera and Planti\'{c}, Iva and \v{C}un\v{c}i\'{c}, Ivan and Krtali\'{c}, Iva and Jureti\'{c}, Marina and Pepi\'{c}, Ivan and Lovri\'{c}, Jasmina and Hafner, Anita}, year = {2017}, pages = {480-487}, DOI = {10.1016/j.ijpharm.2017.05.065}, keywords = {nasal delivery, in situ gelling, alginate, amidated pectin, dexamethasone}, journal = {International journal of pharmaceutics}, doi = {10.1016/j.ijpharm.2017.05.065}, volume = {533}, number = {2}, issn = {0378-5173}, title = {Lipid/alginate nanoparticle-loaded in situ gelling system tailored for dexamethasone nasal delivery}, keyword = {nasal delivery, in situ gelling, alginate, amidated pectin, dexamethasone} }
@article{article, author = {Juri\v{s}i\'{c} Dukovski, Bisera and Planti\'{c}, Iva and \v{C}un\v{c}i\'{c}, Ivan and Krtali\'{c}, Iva and Jureti\'{c}, Marina and Pepi\'{c}, Ivan and Lovri\'{c}, Jasmina and Hafner, Anita}, year = {2017}, pages = {480-487}, DOI = {10.1016/j.ijpharm.2017.05.065}, keywords = {nasal delivery, in situ gelling, alginate, amidated pectin, dexamethasone}, journal = {International journal of pharmaceutics}, doi = {10.1016/j.ijpharm.2017.05.065}, volume = {533}, number = {2}, issn = {0378-5173}, title = {Lipid/alginate nanoparticle-loaded in situ gelling system tailored for dexamethasone nasal delivery}, keyword = {nasal delivery, in situ gelling, alginate, amidated pectin, dexamethasone} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font